Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tissue Registration & Listing Reg Draws Attention To Unissued FDA Rules

This article was originally published in The Gray Sheet

Executive Summary

FDA is implementing new tissue bank registration and listing requirements, though the two remaining parts of the tripartite tissue regulatory framework have yet to be finalized
Advertisement

Related Content

Tissue Donor Eligibility Rule Issued; FDA Good Tissue Practices Rule Awaited
Tissue Donor Eligibility Rule Issued; FDA Good Tissue Practices Rule Awaited
FDA Completes Human Dura Mater Classification, Undeterred By CJD Threat
Tissue Bank Regs Fall Under Increased Senate Govt. Affairs Panel Scrutiny
Tissue Bank Regs Fall Under Increased Senate Govt. Affairs Panel Scrutiny
Advertisement
UsernamePublicRestriction

Register

MT019659

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel